DE69907170D1 - Verwendung einer zusammensetzung zur versehung von glutamine - Google Patents

Verwendung einer zusammensetzung zur versehung von glutamine

Info

Publication number
DE69907170D1
DE69907170D1 DE69907170T DE69907170T DE69907170D1 DE 69907170 D1 DE69907170 D1 DE 69907170D1 DE 69907170 T DE69907170 T DE 69907170T DE 69907170 T DE69907170 T DE 69907170T DE 69907170 D1 DE69907170 D1 DE 69907170D1
Authority
DE
Germany
Prior art keywords
patient
whey protein
protein
composition
providing glutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69907170T
Other languages
English (en)
Other versions
DE69907170T2 (de
Inventor
Julio Boza
Olivier Ballevre
Paul-Andre Finot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69907170(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of DE69907170D1 publication Critical patent/DE69907170D1/de
Application granted granted Critical
Publication of DE69907170T2 publication Critical patent/DE69907170T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69907170T 1998-03-31 1999-02-22 Verwendung einer zusammensetzung zur versehung von glutamine Expired - Lifetime DE69907170T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98201016 1998-03-31
EP98201016 1998-03-31
PCT/EP1999/001274 WO1999049741A1 (en) 1998-03-31 1999-02-22 Method for providing glutamine

Publications (2)

Publication Number Publication Date
DE69907170D1 true DE69907170D1 (de) 2003-05-28
DE69907170T2 DE69907170T2 (de) 2004-03-11

Family

ID=8233542

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907170T Expired - Lifetime DE69907170T2 (de) 1998-03-31 1999-02-22 Verwendung einer zusammensetzung zur versehung von glutamine

Country Status (14)

Country Link
US (1) US8178487B2 (de)
EP (1) EP1065947B1 (de)
CN (1) CN1134227C (de)
AT (1) ATE237957T1 (de)
AU (1) AU3142099A (de)
BR (1) BR9909234A (de)
CA (1) CA2326148C (de)
DE (1) DE69907170T2 (de)
DK (1) DK1065947T3 (de)
ES (1) ES2195555T3 (de)
HK (1) HK1039729A1 (de)
ID (1) ID27818A (de)
PT (1) PT1065947E (de)
WO (1) WO1999049741A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
US6864230B2 (en) 2001-07-31 2005-03-08 Novartis Nutrition Ag Glutamine rich dietary composition
AU2003242695B2 (en) 2002-07-01 2007-12-06 Unilever Plc Satiety inducing composition
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
CN100356876C (zh) * 2005-09-30 2007-12-26 北京康比特威创体育新技术发展有限公司 一种促进运动疲劳恢复的饮料
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
WO2007143794A1 (en) * 2006-06-15 2007-12-21 Murray Goulburn Co-Operative Co. Limited Formulation comprising whey protein and hydrolysates for improving muscle recovery
WO2009052106A2 (en) 2007-10-14 2009-04-23 University Of Florida Research Foundation Inc. Formulation to improve gastrointestinal function
EP2165713B1 (de) * 2008-09-19 2012-11-14 Nestec S.A. Molke und Verbesserung der Thymusfunktion
US10869843B2 (en) * 2010-11-23 2020-12-22 Chemi Nutra Method for increasing muscle mass and strength
EP2802223B1 (de) * 2012-01-09 2017-05-03 N.V. Nutricia Glutaminangereicherte ernährungszusammensetzung für frühgeborene
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CA2901469A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc. Rice protein supplements
US11026913B2 (en) 2013-09-05 2021-06-08 Emory University Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
WO2015154251A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
EP3634155A4 (de) 2017-05-12 2021-02-17 Axiom Foods Inc. Reisprodukte sowie systeme und verfahren zu deren herstellung
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FI904074A0 (fi) * 1989-08-28 1990-08-17 Milupa Ag Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk.
JP2907603B2 (ja) * 1991-09-09 1999-06-21 雪印乳業株式会社 新規生理活性ペプチド、該活性ペプチドを有効成分とする胃酸分泌抑制剤、抗潰瘍剤及び飲食品
JPH07255398A (ja) * 1994-03-16 1995-10-09 Snow Brand Milk Prod Co Ltd 保存安定性及び嗜好性の高い経口経腸栄養組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
US5661123A (en) * 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients
DE19717195C2 (de) * 1997-04-24 2001-09-27 Reichenauer Feil Andrea Instantpulver und daraus herstellbares Getränk
US5849335A (en) 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
EP1123013A1 (de) 1997-06-02 2001-08-16 Société des Produits Nestlé S.A. Produkt und verfahren zur versehung von glutamine
US6019999A (en) 1997-12-03 2000-02-01 Miller; David F. Process for making liposomal ion-exchange whey protein and products thereof
US6051236A (en) 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition

Also Published As

Publication number Publication date
BR9909234A (pt) 2000-11-28
WO1999049741A1 (en) 1999-10-07
ES2195555T3 (es) 2003-12-01
ID27818A (id) 2001-04-26
EP1065947B1 (de) 2003-04-23
EP1065947A1 (de) 2001-01-10
DE69907170T2 (de) 2004-03-11
CN1134227C (zh) 2004-01-14
PT1065947E (pt) 2003-08-29
CA2326148A1 (en) 1999-10-07
AU3142099A (en) 1999-10-18
US20090075862A1 (en) 2009-03-19
DK1065947T3 (da) 2003-07-14
ATE237957T1 (de) 2003-05-15
HK1039729A1 (en) 2002-05-10
US8178487B2 (en) 2012-05-15
CA2326148C (en) 2008-01-29
CN1303238A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
ATE237957T1 (de) Verwendung einer zusammensetzung zur versehung von glutamine
DE69919019D1 (de) Verfahren zur herstellung einer proteinzusammenzetzung und einer diese enthaltenden säuglingsnahrung
ATE366521T1 (de) Verfahren zur verwendung von zusammensetzungen von konjugierter linolsäure die mit isomeren angereichert sind
PT822199E (pt) Polipeptidos monopegilados no terminal-n e metodo para a sua preparacao
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE69941991D1 (de) Verfahren zur Herstellung von L-Aminosäure
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
DK325486D0 (da) Fremgangsmaade til fremme af bakteriers vedhaeftning til mave-tarmkanali dyr og mennesker samt praeparat til anvendelse ved fremgangsmaaden
ATE373082T1 (de) Pre-adipose zelllinien
SE8505048D0 (sv) Nutritionsemulsion med syretransporterande egenskaper
DE3785530T2 (de) Verfahren zur Herstellung von L-Arginin.
DE60205955D1 (de) Verfahren zur Herstellung von L-Aminosäuren
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE406809T1 (de) Zusammensetzungen enthaltend milchproteinkonzentrat und fettsäure und verfahren zur herstellung
BRPI9916549B8 (pt) Composição farmacêutica, proteína, polinucleotídeo
DE50304242D1 (de) Verfahren zur herstellung von acylphosphinoxiden
DE50209165D1 (de) Verfahren zur herstellung von d-pantothensäure und/oder salze als zusatz zu tierfuttermitteln
ATE433676T1 (de) Verwendung einer jodhaltihen verbindung zur herstellung eines iodierten lebensmittelproduktes zur verhinderung von erkrankungen der schilddrüsenfunktion
DE502004004453D1 (de) Verfahren zur enzymatischen herstellung von mono- und diacylglycerid-haltigen emulgatoren
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
BR0308978A (pt) fragmentos de peptìdeos sintéticos ativos
DE69616085D1 (de) Aminonitril-zwischenprodukte zur herstellung von 2-hydroxyethyliminodiessigsäure
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings